Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$16.4 million.

  • Treace Medical Concepts' Net Income towards Common Stockholders fell 650.2% to -$16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.6 million, marking a year-over-year increase of 1820.3%. This contributed to the annual value of -$56.1 million for FY2024, which is 1320.49% down from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Net Income towards Common Stockholders is -$16.4 million, which was down 650.2% from -$17.5 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Net Income towards Common Stockholders ranged from a high of -$619000.0 in Q4 2024 and a low of -$21.3 million during Q2 2024
  • In the last 5 years, Treace Medical Concepts' Net Income towards Common Stockholders had a median value of -$12.4 million in 2023 and averaged -$11.6 million.
  • As far as peak fluctuations go, Treace Medical Concepts' Net Income towards Common Stockholders crashed by 37510.39% in 2021, and later surged by 9029.32% in 2024.
  • Over the past 5 years, Treace Medical Concepts' Net Income towards Common Stockholders (Quarter) stood at -$6.6 million in 2021, then soared by 33.34% to -$4.4 million in 2022, then crashed by 44.54% to -$6.4 million in 2023, then skyrocketed by 90.29% to -$619000.0 in 2024, then crashed by 2546.2% to -$16.4 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$16.4 million for Q3 2025, versus -$17.5 million for Q2 2025 and -$16.1 million for Q1 2025.